Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection

Vaccine

Volumn 14, Issue 12, 1996, Pages 1137-1142

  Nandy, R K ^a   Albert, M John ^b   Ghose, A C ^a  

^a BOSE INSTITUTE   (India)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Antibody response; Cholera; Protection; Vibrio cholerae O139

Indexed keywords

BACTERIAL TOXIN; BACTERIUM ANTIBODY; LIPOPOLYSACCHARIDE; TOXIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; VIBRIO CHOLERAE;

EID: 0030581381     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00035-7     Document Type: Article

References (37)

1. 1 Glass, R.I., Becker, S., Huq, M.I. et al. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 1982, 116, 959-970
2. 2 Glass, R.I., Svennerholm, A.M., Khan, M.R., Huda, S., Haq, I. and Holmgren, J. Seroepidemiological studies of EITor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 1985, 151, 236-242
3. 3 Levine, M.M., Kaper, J.B., Black, R.E. and Clements, M.L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 1983, 47, 510-550
4. 4 Levine, M.M. and Pierce, N.F. Immunity and vaccine development. In Cholera (Eds Barua D. and Greenough III W.B.). Plenum Medical Book Company, New York, 1992 pp. 285-327
5. 5 Majumdar, A.S., Dutta, P., Dutta, D. and Ghose, A.C. Antibacterial and antitoxin responses in the serum and milk of cholera patients. Infect. Immun. 1981, 32, 1-8
6. 6 Svennerholm, A.M., Jertborn, M., Gothefors, L., Karim, A.M.M.M., Sack, D.A. and Holmgren, J. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit whole-cell vaccine. J. Infect. Dis. 1984, 149, 884-893
7. 7 Hall, R.H., Losonsky, G., Silveira, A.P.D. et al. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera. Infect. Immun. 1991, 59, 2508-2512
8. 8 Svennerholm, A.M., Jonson, G. and Holmgren, J. Immunity to Vibrio cholerae infection.In Vibrio cholerae and Cholera: Molecular to Global Perspectives (Eds Wachsmuth I.K., Blake P.A. and Olsvik O.). American Society for Microbiology, Washington, DC 1994, pp. 257-271
9. 9 Clemens, J.D., Van Loon, F., Sack, D.A. et al. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J. Infect. Dis. 1991, 163, 1235-1242
10. 10 Ramamurthy, T., Garg, S., Sharma, R. et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993, 341, 703-704
11. 11 Albert, M.J., Siddique, A.K., Islam, M.S. et al. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 1993, 341, 704
12. 12 Shimada, T., Nair, G.B., Deb, B.C., Albert, M.J., Sack, R.B. and Takeda, Y. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet 1993, 341, 1347
13. 13 Hisatsune, K., Kondo, S., Isshiki, Y., Iguchi, T., Kawamata, Y. and Shimada, T. O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Biochem. Biophys. Res. Commun. 1993, 196, 1309-1315
14. 14 Manning, P.A., Stroeher, U.H. and Morona, R. Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching. In Vibrio cholerae and Cholera: Molecular to Global Perspectives (Eds Wachsmuth, I.K., Blake, P.A. and Olsvik, O.). American Society for Microbiology, Washington, DC 1994, pp. 89-90
15. 15 Nandy, R.K., Sengupta, T.K., Mukhopadhyay, S. and Ghose, A.C. A comparative study on the properties of Vibrio cholerae O139, O1 and other non-O1 strains. J. Med. Microbiol. 1995, 42, 251-257
16. 16 Nair, G.B., Shimada, T., Kurazono, H. et al. Characterization of phenotypic, serological, and toxigenic traits of Vibrio cholerae O139 Bengal. J. Clin. Microbiol. 1994, 32, 2775-2779
17. 17 Albert, M.J., Ansaruzzaman, M., Bardhan, P.K. et al. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 1993, 342, 387-39O
18. 18 Nair, G.B., Ramamurthy, T., Bhattacharya, S.K. et al. Spread of Vibrio cholerae O139 Bengal in India. J. Infect. Dis. 1994, 169, 1029-1034
19. 19 Albert, M.J. Vibrio cholerae O139 Bengal. J. Clin. Microbiol. 1994, 32, 2345-2349
20. 20 Westphal, O. and Jann, K. Bacterial lipopolysaccharides. Extraction with phenol water and further applications of the procedure. Meth. Carbohydr. Chem. 1965, 5, 83-91
21. 21 Sengupta, D., Datta-Roy, K., Banerjee, K. and Ghose, A.C. Identification of some antigenically related outer-membrane proteins of strains of Vibrio cholerae O1 and non-O1 serovars involved in intestinal adhesion and the protective role of antibodies to them. J. Med. Microbiol. 1989, 29, 33-39
22. 22 Tsai, C.M. and Frasch, C.E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 1982, 119, 115-119
23. 23 Cryz, S.J.Jr, Furer, E. and Germanier, R. Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigens. J. Clin. Microbiol. 1982, 16, 41-45
24. 24 Iwanaga, M. and Yamamoto, K. New medium for the production of cholera toxin by Vibrio cholerae O1 biotype EITor. J. Clin. Microbiol. 1985, 22, 405-408
25. 25 Towbin, H., Staehelin, T. and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350-4354
26. 26 Guerrant, R.L., Brunton, L.L., Schnaitman, T.C., Rebhun, L.I. and Gilman, A.G. Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect. Immun. 1974, 1O, 320-327
27. 27 Ujiiye, A., Nakatomi, M., Utsumomiya, K. et al. Experimental cholera in mice. I. First report on the oral infection. Trop. Med. 1968, 1O, 65-71
28. 28 Sengupta, D.K., Sengupta, T.K. and Ghose, A.C. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios. FEMS. Microbiol. Immunol. 1992, 89, 261-266
29. 29 Johnson, J.A., Salles, C.A., Panigrahi, P. et al. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae EITor but has important differences. Infect. Immun. 1994, 62, 2108-2110
30. 30 Weintraub, A., Widmalm, G., Jansson, P.E., Jansson, M., Hultenby, K. and Albert, M.J. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microbiol. Pathogen. 1994, 16, 235-241
31. 31 Meno, Y. and Amako, K. The biological meaning of the capsule-like layer in Vibrio cholerae O139. In Proceedings of the 30th Joint Conference, U.S. Japan Co-operative Medical Science Program, Cholera and Related Diarrheal Diseases, 1994, pp. 67-71
32. 32 Tacket, C.O., Morris, J.G. Jr, Losonsky, G.A. et al. Volunteer studies investigating the pathogenicity of Vibrio cholerae O139 and the protective efficacy conferred by both primary infection and by vaccine strain CVD112. In Proceedings of the 30th Joint Conference, U.S. Japan Co-operative Medical Science Program, Cholera and Related Diarrheal Diseases, 1994, pp. 142-147
33. 33 Jertborn, M., Svennerholm, A.M. and Holmgren, J. IgG and IgA subclass distribution of antitoxin antibody responses after oral cholera vaccination or cholera disease. Int. Archs Allergy. Appl. Immunol. 1988, 85, 358-363
34. 34 Takeda, T., Ramamurthy, T., Saha Chowdhury, A. et al. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients. J. Infect. 1994, 29, 233-235
35. 35 Kaper, J.B., Morris, J.G. Jr and Levine, M.M. Cholera. Clin. Microbiol. Rev. 1995, 8, 48-86
36. 36 Albert, M.J., Alam, K., Ansaruzzaman, M., Qadri, F. and Sack, R.B. Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral Immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR. J. Infect. Dis. 1994, 169, 230-231
37. 37 Albert, M.J., Alam, K., Rahman, A.S., Huda, S. and Sack, R.B. Lack of cross-protection against diarrhea due to Vibro cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal. J. Infect. Dis. 1994, 169, 709-710